Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Caveolin-1 as a potential new therapeutic target in multiple myeloma.
Podar K, Anderson KC. Podar K, et al. Cancer Lett. 2006 Feb 20;233(1):10-5. doi: 10.1016/j.canlet.2005.02.035. Cancer Lett. 2006. PMID: 16473666 Review.
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage.
Tai YT, Teoh G, Lin B, Davies FE, Chauhan D, Treon SP, Raje N, Hideshima T, Shima Y, Podar K, Anderson KC. Tai YT, et al. Among authors: podar k. J Immunol. 2000 Dec 1;165(11):6347-55. doi: 10.4049/jimmunol.165.11.6347. J Immunol. 2000. PMID: 11086072
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.
Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT, Lin B, Podar K, Gupta D, Chauhan D, Treon SP, Richardson PG, Schlossman RL, Morgan GJ, Muller GW, Stirling DI, Anderson KC. Davies FE, et al. Among authors: podar k. Blood. 2001 Jul 1;98(1):210-6. doi: 10.1182/blood.v98.1.210. Blood. 2001. PMID: 11418482
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration.
Podar K, Tai YT, Davies FE, Lentzsch S, Sattler M, Hideshima T, Lin BK, Gupta D, Shima Y, Chauhan D, Mitsiades C, Raje N, Richardson P, Anderson KC. Podar K, et al. Blood. 2001 Jul 15;98(2):428-35. doi: 10.1182/blood.v98.2.428. Blood. 2001. PMID: 11435313
Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P, Anderson KC. Hideshima T, et al. Among authors: podar k. Semin Oncol. 2001 Dec;28(6):607-12. doi: 10.1016/s0093-7754(01)90033-8. Semin Oncol. 2001. PMID: 11740818 Review.
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.
Podar K, Tai YT, Lin BK, Narsimhan RP, Sattler M, Kijima T, Salgia R, Gupta D, Chauhan D, Anderson KC. Podar K, et al. J Biol Chem. 2002 Mar 8;277(10):7875-81. doi: 10.1074/jbc.M109068200. Epub 2001 Dec 20. J Biol Chem. 2002. PMID: 11751905
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI, Anderson KC. Gupta D, et al. Among authors: podar k. Leukemia. 2001 Dec;15(12):1950-61. doi: 10.1038/sj.leu.2402295. Leukemia. 2001. PMID: 11753617
CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells.
Tai YT, Podar K, Gupta D, Lin B, Young G, Akiyama M, Anderson KC. Tai YT, et al. Among authors: podar k. Blood. 2002 Feb 15;99(4):1419-27. doi: 10.1182/blood.v99.4.1419. Blood. 2002. PMID: 11830495
Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.
Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC, Anderson KC. Chauhan D, et al. Among authors: podar k. Oncogene. 2002 Feb 21;21(9):1346-58. doi: 10.1038/sj.onc.1205205. Oncogene. 2002. PMID: 11857078
Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications.
Tai YT, Podar K, Kraeft SK, Wang F, Young G, Lin B, Gupta D, Chen LB, Anderson KC. Tai YT, et al. Among authors: podar k. Exp Hematol. 2002 Mar;30(3):212-20. doi: 10.1016/s0301-472x(01)00786-x. Exp Hematol. 2002. PMID: 11882358
135 results
Jump to page